FSCN1 and breast cancer: A large cohort of breast cancer patients from the publicly available Kaplan–Meier plotter portal dataset [24] was used to assess fascin expression and its impact on overall survival (OS; n = 1879), recurrence-free survival (RFS; n = 4929) and distant metastasis-free survival (DMFS; n = 2764).